Ardalan M, Shoja M M
Nephrology Department, Tabriz University of Medical Sciences, Tabriz, Iran.
Transplant Proc. 2009 Sep;41(7):2915-6. doi: 10.1016/j.transproceed.2009.07.024.
Cytomegalovirus (CMV) is an important pathogen in organ-transplant recipients. There have been frequent reports of CMV-induced adrenal insufficiency in patients with human immunodeficiency virus infection. Herein, we report CMV-induced renal insufficiency in a renal transplant recipient. A 24-year-old woman had gradual onset of weakness, anorexia, nausea, hypotension, and skin hyperpigmentation at 5 months after renal transplantation. The immunosuppression regimen included cyclosporine, mycophenolate mofetil, and corticosteroid (prednisolone, 5 mg/d). Recent history included acute CMV infection, which was treated with ganciclovir. Basal serum cortisol concentration was 4 microg/dL, and stimulated serum cortisol concentration was less than 10 microg/dL. All clinical signs and symptoms and hypotension gradually improved after the oral prednisolone dose was increased to 10 mg/d. Clinicians must be aware of the possibility of CMV-induced adrenal insufficiency in renal transplant recipients. The condition may be symptomatic despite low-dose prednisolone therapy.
巨细胞病毒(CMV)是器官移植受者中的一种重要病原体。人类免疫缺陷病毒感染患者中,CMV诱发肾上腺功能不全的报道屡见不鲜。在此,我们报告1例肾移植受者发生CMV诱发的肾功能不全。一名24岁女性在肾移植术后5个月逐渐出现乏力、厌食、恶心、低血压及皮肤色素沉着。免疫抑制方案包括环孢素、霉酚酸酯和皮质类固醇(泼尼松龙,5mg/d)。近期病史包括曾接受更昔洛韦治疗的急性CMV感染。基础血清皮质醇浓度为4μg/dL,刺激后血清皮质醇浓度低于10μg/dL。口服泼尼松龙剂量增至10mg/d后,所有临床症状和体征及低血压逐渐改善。临床医生必须意识到肾移植受者发生CMV诱发肾上腺功能不全的可能性。尽管采用小剂量泼尼松龙治疗,该病症仍可能出现症状。